![Clinical Lab Services Market to Be Worth More than $125.6 Billion by 2030](https://www.g2intelligence.com/wp-content/uploads/2023/03/March15-2023.News_.ClinicalLabServicesReport-iStock-619388016_1800x1250-1080x675.jpg)
Clinical Lab Services Market to Be Worth More than $125.6 Billion by 2030
A recently released report estimates that the US market will grow at a CAGR of 4.2 percent over the next seven years.
A recently released report estimates that the US market will grow at a CAGR of 4.2 percent over the next seven years.
According to the FDA’s recently-released annual report, only 135 devices received the designation last year, versus 213 in 2021.
Roche and Abbott received the most approvals for new lab tests last year.
Experts share new strategies for dealing with hemolysis, icterus, and lipemia interference.
More companies have begun offering neurofilament light chain blood tests as a cost-effective alternative to conventional methods.